Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients

被引:0
|
作者
Y Wang
T K Choueiri
J-L Lee
M-H Tan
S Y Rha
S A North
C K Kollmannsberger
D F McDermott
D Y C Heng
机构
[1] University of Calgary,Department of Oncology
[2] Kidney Cancer Center,Division of Hematology/Oncology, Department of Medicine
[3] Dana-Farber Cancer Institute/Brigham and Women's Hospital,undefined
[4] Harvard Medical School,undefined
[5] Asan Medical Center,undefined
[6] University of Ulsan College of Medicine,undefined
[7] National Cancer Centre,undefined
[8] Yonsei Cancer Center,undefined
[9] Yonsei University College of Medicine,undefined
[10] Cross Cancer Institute,undefined
[11] British Columbia Cancer Agency,undefined
[12] Beth Israel Deaconess Medical Center,undefined
[13] Tom Baker Cancer Centre,undefined
[14] University of Calgary,undefined
来源
British Journal of Cancer | 2014年 / 110卷
关键词
sunitinib; sorafenib; ethnicity; VEGF; progression-free survival; overall survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1433 / 1437
页数:4
相关论文
共 50 条
  • [21] Fetal abdominal circumference differences between Asian and non-asian pregnancies with gestational diabetes: Implications for fetal-based therapy in a US population
    Quevedo, Stephen F.
    Rambikur, Elizabeth
    Kington, Randi
    Bovbjerg, Marit
    [J]. DIABETES, 2008, 57 : A508 - A509
  • [22] Is There a Distinct Phenotype for Non-Asian Moyamoya Patients?.
    Gatollari, Hajere J.
    Miller, Eliza C.
    Boehme, Amelia K.
    Connolly, E. Sander
    Elkind, Mitchell S.
    Willey, Joshua Z.
    [J]. STROKE, 2019, 50
  • [23] Is there a distinct phenotype for non-Asian moyamoya patients?
    Gatollari, Hajere J.
    Miller, Eliza C.
    Boehme, Amelia K.
    Connolly, E. Sander
    Elkind, Mitchell S. V.
    Willey, Joshua Z.
    [J]. NEUROLOGY, 2019, 92 (15)
  • [24] Treatment response between Asian and non-Asian patients with type 2 diabetes: is there any similarity or difference?
    Cai, Xiao-Ling
    Ji, Li-Nong
    [J]. CHINESE MEDICAL JOURNAL, 2019, 132 (01) : 1 - 3
  • [25] Comparison of Crizotimb (PF-02341066) Pharmacokinetics between Asian and Non-Asian Patients with Advanced Malignancies
    Ou, Sai Hong Ignatius
    Salgia, Ravi
    Clark, Jeffrey
    Kwak, Eunice L.
    Camidge, David Ross
    Maki, Robert
    Bang, Yung-Jue
    Solomon, Ben
    Tan, Weiwei
    Shapiro, Geoffrey I.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S382 - S382
  • [26] Treatment response between Asian and non-Asian patients with type 2 diabetes: is there any similarity or difference?
    Cai Xiao-Ling
    Ji Li-Nong
    [J]. 中华医学杂志(英文版), 2019, 132 (01) : 1 - 3
  • [28] DIFFERENCES IN PERCEIVED PARENTAL CARE AND PROTECTION AND RELATED PSYCHOLOGICAL DISTRESS BETWEEN BRITISH-ASIAN AND NON-ASIAN ADOLESCENTS
    SHAMS, M
    WILLIAMS, R
    [J]. JOURNAL OF ADOLESCENCE, 1995, 18 (03) : 329 - 348
  • [29] Clinical profile of dasatinib in Asian and non-Asian patients with chronic myeloid leukemia
    Kim, Dong-Wook
    Goh, Yeow-Tee
    Hsiao, Hui-Hua
    Caguioa, Priscilla B.
    Kim, Dongho
    Kim, Wan-Seok
    Saikia, Tapan
    Agrawal, Shruti
    Roy, Amit
    Dai, David
    Bradley-Garelik, M. Brigid
    Mukhopadhyay, Jaydip
    Jootar, Saengsuree
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (05) : 664 - 672
  • [30] Clinical profile of dasatinib in Asian and non-Asian patients with chronic myeloid leukemia
    Dong-Wook Kim
    Yeow-Tee Goh
    Hui-Hua Hsiao
    Priscilla B. Caguioa
    Dongho Kim
    Wan-Seok Kim
    Tapan Saikia
    Shruti Agrawal
    Amit Roy
    David Dai
    M. Brigid Bradley-Garelik
    Jaydip Mukhopadhyay
    Saengsuree Jootar
    [J]. International Journal of Hematology, 2009, 89 : 664 - 672